Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
Toxo 2024
Programm
Poster
Personen
Suche
DE
Zurück
Session
Session V: Metabolism, Biochemistry & Drug Development
Termin
Datum:
Di, 28.05.2024
Zeit:
09:00
–
10:30
Ort / Stream:
Goethe-Saal & Galerie
Vorsitzende
Dr. Eden Yifrach
Cambridge / US
Dr. Julia Romano
Baltimore, MD / US
Programm
09:00
–
09:15
12 Min.
3 Min.
Oral presentation
T32
A novel component of the cytosolic iron-sulfur biogenesis pathway, TgHCF101, as a potential drug target in
Toxoplasma gondii
Eléa Renaud (Montpellier / FR)
Cell Biology
09:15
–
09:30
12 Min.
3 Min.
Oral presentation
T33
Exploring redundancies in central carbon metabolism in
Toxoplasma
parasites
Capella S Maguire (Canberra / AU)
Cell Biology
09:30
–
09:45
12 Min.
3 Min.
Oral presentation
T34
The regulation of the constant flux of fatty-acids relies on key acyltransferases regulating the nutrient flexibility in
Toxoplasma gondii.
Sarah Charital (La Tronche / FR)
Metabolism, Biochemistry & Drug Development
09:45
–
10:00
12 Min.
3 Min.
Oral presentation
T35
Genetic screens in physiological contexts nominate metabolic pathways for deep learning-assisted drug discovery
Christopher J. Giuliano (Cambridge / US)
Metabolism, Biochemistry & Drug Development
10:00
–
10:15
12 Min.
3 Min.
Oral presentation
T36
Genetic deletion of an essential lipid storage enzyme attenuates the virulence of
Toxoplasma
gondii
Dr. Shahbaz Khan (Baltimore / US)
Metabolism, Biochemistry & Drug Development
10:15
–
10:30
12 Min.
3 Min.
Oral presentation
T37
A drug repositioning strategy identifies a compound inhibiting
GSK3 activity in
Toxoplasma gondii
Silvia Diaz-Martin (Grenoble / FR)
Metabolism, Biochemistry & Drug Development
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz